Study links gene with DiGeorge heart defects:
This article was originally published in Clinica
Executive Summary
A US team has discovered a critical gene responsible for cardiovascular defects in patients with DiGeorge Syndrome, a hereditary condition claimed to be the second leading cause of heart disease in children. The discovery of the gene, called Tbx1, paves the way for prenatal testing for a defect associated with the gene, thus opening the door to treatment at birth or to the new surgical techniques developed for patients still in the womb. The finding is described by researchers from the University of Pennsylvania Medical Center and Albert Einstein College of Medicine in the journal Cell (February 23).
You may also be interested in...
Can Organovo Leverage Its Solid Phase II Data In MASH?
Cash-limited Organovo has an FXR agonist showing competitive efficacy and tolerability in MASH, but may need a partner to move forward in that disease as it may be prioritizing its IBD program.
Cullinan Changes Tracks, Moving Lymphoma Bispecific Into Autoimmune
The company will discontinue its trial of the CD19-directed bispecific CLN-978 in NHL and develop it in inflammatory diseases, where it could have an edge over CAR-Ts.
Interview: Theradaptive To Enter Clinical Trial For Spinal Fusion Gel
Theradaptive, which makes a device-biologic combination product to help speed bone healing, recently got authorization to start human trials from the US FDA. Medtech Insight spoke to CEO Luis Alvarez about the company’s past, present and future.